Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis-Reference-Cited by-同舟云学术

Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis

Published:2019-06-18 Issue:8 Volume:3 Page:1073-1084
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Chen Vincent L.¹²,Wright Andrew P.¹³,Halligan Brian¹,Chen Yanhua¹,Du Xiaomeng¹,Handelman Samuel K.¹²,Long Michelle T.⁴,Kiel Douglas P.⁵⁶,Speliotes Elizabeth K.¹²

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine University of Michigan Health System Ann Arbor MI

2. Department of Computational Medicine and Bioinformatics University of Michigan Medical School Ann Arbor MI

3. Division of Gastroenterology Loma Linda University Health Loma Linda CA

4. Section of Gastroenterology Boston Medical Center, Boston University School of Medicine Boston MA

5. Hebrew SeniorLife Institute for Aging Research, Department of Medicine Beth Israel Deaconess Medical Center Boston MA

6. Harvard Medical School Boston MA

Funder

University of Michigan Training in Basic and Translational Digestive Sciences T32

The University of Michigan Department of Internal Medicine

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1391

Reference41 articles.

1. Genetics, diagnostics and therapeutic advances in NAFLD

2. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study;Eguchi Y;J Gastroenterol,2009

3. Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

4. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

5. Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort;Journal of Hepatology;2024-09

2. Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes;Obesity Science & Practice;2024-07

3. Association of the fat mass index with hepatic steatosis and fibrosis: evidence from NHANES 2017–2018;Scientific Reports;2024-03-23

4. A Male Japanese Patient with Temple Syndrome Complicated by Type 2 Diabetes Mellitus;Internal Medicine;2024

5. Circulating organochlorine pesticide levels, genetic predisposition and the risk of incident type 2 diabetes;Environmental Pollution;2023-11